Episode 232: Belzutifan in Early and Late Renal Cancer

We’re joined by Toni Choueiri, MD, and Brian Shuch, MD, to discuss several studies on the use of belzutifan alone and in combination with other treatments in patients with early and late-stage renal cancer, as well as patients with Von Hippel-Lindau syndrome and advanced sporadic RCC.
Dr. Shuch is the director of the University of Califonia, Los Angeles’s Kidney Cancer Program and is the Alvin & Carrie Meinhardt Endowed Chair in Kidney Cancer Research.
Dr. Choueiri is the director of Dana-Farber Cancer Institute’s Lank Center for Genitourinary Oncology, and serves as medical director of Dana-Farber’s International Strategic Initiatives.